Immatics N.V. Ordinary Shares — Graphique, cours et actualités (NASDAQ:IMTX) | MetaTrader

Afficher le graphique complet Full chart

Financials

Aperçu Relevé Statistiques

Trimestriel Annuel

Market Capitalization 15.43 M
Employee 407
Founded 2000
CEO Harpreet Singh
Website www.immatics.com
Headquarter Netherlands
FIGI N/A
Industry Biotechnologies

Nouvelles

Le BPA de Immatics NV a manqué les attentes de 0,04€, le CA en dessous des prévisions

Immatics (IMTX) Reports Q1 Loss, Lags Revenue Estimates

ACAD Q1 Earnings & Revenues Miss Estimates Despite Y/Y Sales Growth

Madrigal Q1 Earnings Beat, MASH Drug Sales Drive Top Line, Stock Up

RXRX Q1 Loss Narrower Than Expected, Revenues Decline Y/Y

Prime Medicine, Inc. (PRME) Reports Q1 Loss, Misses Revenue Estimates

All You Need to Know About Immatics (IMTX) Rating Upgrade to Buy

NVO Q1 Earnings & Sales Top Estimates, 2026 Outlook Raised, Stock Up

Twist Bioscience (TWST) Reports Q2 Loss, Beats Revenue Estimates

TD Cowen initie la couverture d’Immatics avec une recommandation d’achat

Immatics annonce quatre présentations orales lors du congrès ASCO

Immatics: Buying The Anzu-Cel Floor, Playing The Moderna Moonshot (NASDAQ:IMTX)